Motley Fool Wealth Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,077
| Closed | -$206K | – | 123 |
|
|
2024
Q2 | $206K | Sell |
1,077
-10
| -0.9% | -$2.03K | 0.01% | 120 |
|
|
2024
Q1 | $215K | Buy |
+1,087
| New | +$199K | 0.01% | 120 |
|
|
2023
Q3 | – | Sell |
-1,431
| Closed | -$313K | – | 124 |
|
|
2023
Q2 | $313K | Sell |
1,431
-71,782
| -98% | -$16M | 0.02% | 121 |
|
|
2023
Q1 | $16M | Sell |
73,213
-1,314
| -2% | -$285K | 1% | 34 |
|
|
2022
Q4 | $15.5M | Sell |
74,527
-2,495
| -3% | -$548K | 1.08% | 31 |
|
|
2022
Q3 | $16.8M | Sell |
77,022
-6,591
| -8% | -$1.5M | 1.1% | 32 |
|
|
2022
Q2 | $17.5M | Sell |
83,613
-2,713
| -3% | -$578K | 1.1% | 30 |
|
|
2022
Q1 | $20.9M | Sell |
86,326
-1,317
| -2% | -$319K | 1% | 35 |
|
|
2021
Q4 | $22.8M | Sell |
87,643
-2,010
| -2% | -$522K | 0.99% | 36 |
|
|
2021
Q3 | $23.6M | Sell |
89,653
-1,050
| -1% | -$287K | 1.03% | 35 |
|
|
2021
Q2 | $22.4M | Sell |
90,703
-990
| -1% | -$208K | 0.94% | 37 |
|
|
2021
Q1 | $17.8M | Sell |
91,693
-352
| -0.4% | -$70.6K | 0.8% | 45 |
|
|
2020
Q4 | $19.6M | Buy |
92,045
+1,048
| +1% | +$209K | 0.87% | 40 |
|
|
2020
Q3 | $15.6M | Buy |
90,997
+2,607
| +3% | +$481K | 0.81% | 40 |
|
|
2020
Q2 | $17M | Buy |
88,390
+597
| +0.7% | +$97.7K | 0.96% | 35 |
|
|
2020
Q1 | $12.9M | Sell |
87,793
-1,814
| -2% | -$289K | 0.93% | 38 |
|
|
2019
Q4 | $13.9M | Sell |
89,607
-89,732
| -50% | -$12.9M | 0.83% | 40 |
|
|
2019
Q3 | $24.2M | Sell |
179,339
-1,364
| -0.8% | -$179K | 1.6% | 19 |
|
|
2019
Q2 | $22.1M | Sell |
180,703
-2,045
| -1% | -$227K | 1.38% | 22 |
|
|
2019
Q1 | $19M | Sell |
182,748
-2,988
| -2% | -$308K | 1.22% | 25 |
|
|
2018
Q4 | $21.1M | Buy |
185,736
+4,409
| +2% | +$472K | 1.61% | 21 |
|
|
2018
Q3 | $20.9M | Buy |
181,327
+302
| +0.2% | +$33.1K | 1.34% | 26 |
|
|
2018
Q2 | $18.8M | Buy |
181,025
+2,940
| +2% | +$297K | 1.32% | 25 |
|
|
2018
Q1 | $17.5M | Buy |
178,085
+6,497
| +4% | +$614K | 1.29% | 24 |
|
|
2017
Q4 | $14.5M | Sell |
171,588
-6,084
| -3% | -$503K | 1.12% | 26 |
|
|
2017
Q3 | $13.7M | Buy |
177,672
+3,698
| +2% | +$283K | 1.16% | 24 |
|
|
2017
Q2 | $13.5M | Buy |
173,974
+42,668
| +32% | +$3.05M | 1.23% | 25 |
|
|
2017
Q1 | $9.45M | Buy |
131,306
+14,499
| +12% | +$1M | 0.91% | 32 |
|
|
2016
Q4 | $7.25M | Buy |
+116,807
| New | +$7.15M | 0.77% | 37 |
|
Other funds holding RMD
Motley Fool Wealth Management's RMD Position: Q3 2024 in Review
Motley Fool Wealth Management sold out of ResMed (RMD) in Q3 2024, closing a stake of 1,077 shares — an estimated $206K sold.
Motley Fool Wealth Management first reported a position in RMD in Q4 2016 and held it in 29 quarters. The position peaked at $24.2M in Q3 2019. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.
- Motley Fool Wealth Management reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
- Motley Fool Wealth Management sold 1,077 ResMed shares in Q3 2024, an estimated $206K.
- Motley Fool Wealth Management first reported a position in ResMed in Q4 2016 and held it in 29 quarters.
- Motley Fool Wealth Management's ResMed position peaked at $24.2M in Q3 2019.
- 802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.
Based on Motley Fool Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.